Method for purifying vitamin k-dependent proteins such as coagulation factor ix
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- OCTAPHARMA
- Publication Date
- 2016-06-01
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The present invention relates to a method for purifying a vitamin K-dependent protein such as blood coagulation factor IX (abbreviated as FIX) and a fraction comprising a vitamin K-dependent protein such as FIX obtainable by the method of the present invention. Background technique
[0002] Hemophilia is a genetic disorder that impairs the body's ability to control blood clotting, or blood clotting. In one of its forms, hemophilia B, a deficiency of blood clotting factor IX, or FIX for short, occurs in about 1 in 25,000 males. Factor IX (or Christmas factor) is a serine protease of the coagulation system. It is a vitamin K-dependent plasma protein, through the Ca 2+ Participates in coagulation by converting factor X to its active form in the presence of ions, phospholipids and factor VIIIa. FIX proteins are essential factors of blood coagulation with multifunctional properties.
[0003] Factor IX (FIX) is a single-chain glycoprotein comprising 461 ...